Target intelligence / Profile preview

Natural killer cell-activating receptor NKp46 (NKp46)

Target
NKp46
Molecular classification
Receptor, Immunoglobulin superfamily
01

Overview

NKp46 is a crucial activating receptor on natural killer (NK) cells, facilitating the lysis of tumor and virus-infected cells by binding specific ligands. It consists of two C2-type Ig-like domains and plays a significant role in antitumor immunity and responses to viral infections. This receptor is part of the immunoglobulin superfamily and lacks an intrinsic ITAM but transduces signals by associating with ITAM-containing adapters. NKp46 is expressed on NK cells and certain subsets of innate lymphoid cells and T cells, contributing to both innate and adaptive immunity. Its role in recognizing and killing target cells makes it a significant component in cancer and infection therapies.

Other names
NCR1CD335
02

Mechanism of action

NKp46 activates NK cell activity through association with ITAM-containing signaling molecules like CD3ζ or FcRγ, leading to the phosphorylation of tyrosine residues and subsequent signal transduction[2][3].

03

Biological functions

Immune responseSignal transductionCell killingAntitumor activity
04

Disease associations

CancerInfection (viral, fungal, bacterial)Autoimmune diseases
05

Safety considerations

Generally, manipulating NKp46 could affect immune balance and potentially lead to autoimmune issues if not managed carefully.
06

Biomarkers

Potential biomarkers could include NKp46 expression levels in relation to disease states like cancer or viral infections[2].

Beyond the preview

Go deeper on Natural killer cell-activating receptor NKp46 (NKp46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell-activating receptor NKp46 (NKp46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call